N-Acetylcysteine and Macular Degeneration

 A large study from Taiwan found that people who took the antioxidant N-acetylcysteine (NAC) had a
much lower risk of developing age-related macular degeneration (AMD). The study used national health insurance data and included over 5,000 NAC users and 5,000 non-users. NAC users showed a significantly lower risk of both dry and wet AMD, especially at higher doses, suggesting a dose-response effect.

NAC helps protect cells by reducing oxidative stress and inflammation, both key factors in AMD. However, the benefit was mainly seen in those taking larger or longer-term doses, and the data for wet AMD were less certain due to fewer cases. The authors caution that, since this was a retrospective database study, more prospective clinical research is needed to confirm NAC’s protective role and clarify the optimal dosage.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH